+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Prospective Evaluation of the Awareness, Knowledge, and Management of Osteoporosis in a Cohort of Medical Staff


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.



          To investigate the differences in the awareness, knowledge, and management of osteoporosis from a cohort of medical staff after educational intervention.


          A total of 653 medical workers from different departments related to the prevention and treatment of osteoporosis from 7 hospitals in Ningxia were enrolled. Information was collected using a designed questionnaire.


          After 5 years of educational intervention and follow-up, medical staff had an increased understanding of osteoporosis diagnosis, including dual-energy X-ray, ultrasound bone sonometer, fragility fracture history, biochemistry markers, and the awareness of the susceptible population. However, there was no improvement in the cognition of single/dual photo absorptiometry, symptoms and signs, and bone turnover index. Their understanding of antiosteoporosis drugs, especially the application of calcitonin, diphosphates, and vitamin D, was significantly promoted, while the perception of indicators and time in follow-up, some adverse drug reactions, and exercise therapy remained unchanged. Medical staff were remarkably less aware of the management of follow-up for osteoporosis, exercise and diet therapy, and bone turnover markers.


          A great gap was identified in the perception of osteoporosis among medical staff in the Ningxia region. After the educational intervention, the knowledge regarding some aspects of osteoporosis generally improved. Much more effort should be made to strengthen the training and learning on the special detection methods of osteoporosis, medications and exercise therapy, and follow-up management.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Osteoporosis prevention, diagnosis, and therapy.

          To clarify the factors associated with prevention, diagnosis, and treatment of osteoporosis, and to present the most recent information available in these areas. From March 27-29, 2000, a nonfederal, nonadvocate, 13-member panel was convened, representing the fields of internal medicine, family and community medicine, endocrinology, epidemiology, orthopedic surgery, gerontology, rheumatology, obstetrics and gynecology, preventive medicine, and cell biology. Thirty-two experts from these fields presented data to the panel and an audience of 699. Primary sponsors were the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institutes of Health Office of Medical Applications of Research. MEDLINE was searched for January 1995 through December 1999, and a bibliography of 2449 references provided to the panel. Experts prepared abstracts for presentations with relevant literature citations. Scientific evidence was given precedence over anecdotal experience. The panel, answering predefined questions, developed conclusions based on evidence presented in open forum and the literature. The panel composed a draft statement, which was read and circulated to the experts and the audience for public discussion. The panel resolved conflicts and released a revised statement at the end of the conference. The draft statement was posted on the Web on March 30, 2000, and updated with the panel's final revisions within a few weeks. Though prevalent in white postmenopausal women, osteoporosis occurs in all populations and at all ages and has significant physical, psychosocial, and financial consequences. Risks for osteoporosis (reflected by low bone mineral density [BMD]) and for fracture overlap but are not identical. More attention should be paid to skeletal health in persons with conditions associated with secondary osteoporosis. Clinical risk factors have an important but poorly validated role in determining who should have BMD measurement, in assessing fracture risk, and in determining who should be treated. Adequate calcium and vitamin D intake is crucial to develop optimal peak bone mass and to preserve bone mass throughout life. Supplementation with these 2 nutrients may be necessary in persons not achieving recommended dietary intake. Gonadal steroids are important determinants of peak and lifetime bone mass in men, women, and children. Regular exercise, especially resistance and high-impact activities, contributes to development of high peak bone mass and may reduce risk of falls in older persons. Assessment of bone mass, identification of fracture risk, and determination of who should be treated are the optimal goals when evaluating patients for osteoporosis. Fracture prevention is the primary treatment goal for patients with osteoporosis. Several treatments have been shown to reduce the risk of osteoporotic fractures, including those that enhance bone mass and reduce the risk or consequences of falls. Adults with vertebral, rib, hip, or distal forearm fractures should be evaluated for osteoporosis and given appropriate therapy.
            • Record: found
            • Abstract: found
            • Article: not found

            Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention.

            Fragility fractures are common, affecting almost one in two older women and one in three older men. Every fragility fracture signals increased risk of future fractures as well as risk of premature mortality. Despite the major health care impact worldwide, currently there are few systems in place to identify and "capture" individuals after a fragility fracture to ensure appropriate assessment and treatment (according to national guidelines) to reduce future fracture risk and adverse health outcomes. The Task Force reviewed the current evidence about different systematic interventional approaches, their logical background, as well as the medical and ethical rationale. This included reviewing the evidence supporting cost-effective interventions and developing a toolkit for reducing secondary fracture incidence. This report presents this evidence for cost-effective interventions versus the human and health care costs associated with the failure to address further fractures. In particular, it summarizes the evidence for various forms of Fracture Liaison Service as the most effective intervention for secondary fracture prevention. It also summarizes the evidence that certain interventions, particularly those based on patient and/or community-focused educational approaches, are consistently, if unexpectedly, ineffective. As an international group, representing 36 countries throughout Asia-Pacific, South America, Europe, and North America, the Task Force reviewed and summarized the international data on barriers encountered in implementing risk-reduction strategies. It presents the ethical imperatives for providing quality of care in osteoporosis management. As part of an implementation strategy, it describes both the quality improvement methods best suited to transforming care and the research questions that remain outstanding. The overarching outcome of the Task Force's work has been the provision of a rational background and the scientific evidence underpinning secondary fracture prevention and stresses the utility of one form or another of a Fracture Liaison Service in achieving those quality outcomes worldwide. © 2012 American Society for Bone and Mineral Research. Copyright © 2012 American Society for Bone and Mineral Research.
              • Record: found
              • Abstract: found
              • Article: not found

              Estimating prevalence of osteoporosis: examples from industrialized countries.

              In nine industrialized countries in North America, Europe, Japan, and Australia, country-specific osteoporosis prevalence (estimated from published data) at the total hip or hip/spine ranged from 9 to 38 % for women and 1 to 8 % for men. In these countries, osteoporosis affects up to 49 million individuals.

                Author and article information

                Comput Math Methods Med
                Comput Math Methods Med
                Computational and Mathematical Methods in Medicine
                28 May 2022
                : 2022
                : 4201180
                1Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China
                2General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China
                3Department of Geriatrics and Special Needs, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China
                Author notes

                Academic Editor: Osamah Ibrahim Khalaf

                Author information
                Copyright © 2022 Xiaoling Zhou et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                : 15 November 2021
                : 10 May 2022
                : 17 May 2022
                Funded by: Ningxia Medical University
                Award ID: NXYLXK2017A05
                Funded by: Key Science and technology project in Ningxia
                Award ID: 2020BFG02011
                Research Article

                Applied mathematics
                Applied mathematics


                Comment on this article